fingolimod hydrochloride

Drug ingredient

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 162359-56-0

Where It Comes From

32 FDA-registered drug labelers
Accord Healthcare Inc.
Alivus Life Sciences Limited
Apotex Corp.
Ascend Laboratories, LLC
Aurobindo Pharma Limited
AvKARE
BIOCON LIMITED
Biocon Pharma Inc.
Camber Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Inc
Emcure Pharmaceuticals Limited
Everlight Chemical Industrial Corporation Kuanyin II Plant
Glenmark Pharmaceuticals Inc., USA
Honour Lab Limited
Maprimed S.A.
MSN Laboratories Private Limited
MYLAN LABORATORIES LIMITED
Novartis Pharma Schweizerhalle AG
Novartis Pharma Stein AG
Novartis Pharmaceuticals Corporation
Quallent Pharmaceuticals Health LLC
Rising Pharma Holdings, Inc.
Ruyuan HEC Pharm Co., Ltd.
SHILPA PHARMA LIFESCIENCES LIMITED
SUN PHARMACEUTICAL INDUSTRIES, INC.
TAPI Czech Industries s.r.o.
Teva Czech Industries s.r.o
Teva Pharmaceuticals, Inc.
Viyash Life Sciences Private Limited
XLCare Pharmaceuticals Inc.
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 3 drug and cosmetic product listings (FDA).

  • Fingolimod
  • Fingolimod Hydrochloride
  • Gilenya
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS162359-56-0
PubChem CID107969
DTXSIDDTXSID00167364
FormulaC19H34ClNO2
Mol. Weight343.9 g/mol
SMILESCCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl

Data Sources

1079692026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/fingolimod hydrochloride/cids/JSON

Archive: data/sources/pubchem_name/fingolimod hydrochloride.json

CAS 162359-56-02026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

bulk match2026-04-07

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json